How to treat children with positive Mycoplasma pneumoniae antibodies

Treatment of positive Mycoplasma pneumoniae antibodies in children is tailored to the following criteria:

If the child is positive for Mycoplasma pneumoniae antibody, if there are no uncomfortable symptoms, it is necessary to consider the possibility of previous infection with Mycoplasma pneumoniae, and no special treatment is required, and temporary observation can be made.Some children with positive Mycoplasma pneumoniae antibody are accompanied by respiratory tract infection symptoms such as recurrent fever, cough, wheezing, and shortness of breath, and need to be considered in the acute phase of infection. Anti-infective treatment with macrolide antibiotics, such as erythromycin and azithromycin, is recommended. Some children with positive Mycoplasma pneumoniae antibody are accompanied by obvious dyspnea, and the treatment effect of macrolide antibiotics is not good, and they need to be hospitalized as soon as possible, and they need to be vigilant for bacterial infection or refractory Mycoplasma pneumoniae infection. Empirically administering sensitive intravenous antibiotics and, if necessary, glucocorticoids, is recommended to aggressively prevent complications. Symptomatic treatment, such as cough and expectorant and nebulization, is also required. The more commonly used drugs include carbocisteine oral solution, cough syrup, and nebulized inhaled albuterol nebulized solution. Mycoplasma pneumoniae infection is highly contagious, so it is recommended to properly isolate the respiratory tract and avoid close contact with other people to reduce the probability of cross-infection. In addition, it is also necessary to strengthen the nutritional intake, mainly light, which helps digestion and absorption and avoids indigestion.